Publications

Development of Cell-Permeable, Non-Helical Constrained Peptides to Target a Key Protein-Protein Interaction in Ovarian Cancer

Authors: MM Wiedmann, YS Tan, Y Wu, S Aibara, W Xu, HF Sore, CS Verma, L Itzhaki, M ...

E-pub date: 9 Jan 2017

Journal name: Angewandte Chemie

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.

Authors: KW Pajtler, SC Mack, V Ramaswamy, CA Smith, H Witt, A Smith, JR Hansford, K...

E-pub date: 1 Jan 2017

Journal name: Acta Neuropathol

Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis.

Authors: S Sivakumar, I de Santiago, L Chlon, F Markowetz

E-pub date: 1 Jan 2017

Journal name: PLoS Med

Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.

Authors: E Sala, E Mema, Y Himoto, H Veeraraghavan, JD Brenton, A Snyder, B Weigelt,...

E-pub date: 1 Jan 2017

Journal name: Clin Radiol

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.

Authors: EM Swisher, KK Lin, AM Oza, CL Scott, H Giordano, J Sun, GE Konecny, RL Col...

E-pub date: 1 Jan 2017

Journal name: Lancet Oncol

Deciphering the divergent roles of progestogens in breast cancer.

Authors: JS Carroll, TE Hickey, GA Tarulli, M Williams, WD Tilley

E-pub date: 1 Jan 2017

Journal name: Nat Rev Cancer

MRI measurements of reporter-mediated increases in transmembrane water exchange enable detection of a gene reporter.

Authors: F Schilling, S Ros, D-E Hu, P D'Santos, S McGuire, R Mair, AJ Wright, E Man...

E-pub date: 1 Jan 2017

Journal name: Nat Biotechnol

Validation and Performance of a Standardized ctDNA NGS Assay across Two Laboratories

Authors: T Forshew, A Lawson, S Smalley, V Plagnol, J Calaway, S Blais, K Howarth, G...

E-pub date: 1 Jan 2017

Journal name: Journal of Thoracic Oncology

Filters

Research Groups

Core Facilities

Start date

End date

Development of Cell-Permeable, Non-Helical Constrained Peptides to Target a Key Protein-Protein Interaction in Ovarian Cancer

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.

Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis.

Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.

Deciphering the divergent roles of progestogens in breast cancer.

MRI measurements of reporter-mediated increases in transmembrane water exchange enable detection of a gene reporter.

Validation and Performance of a Standardized ctDNA NGS Assay across Two Laboratories

Themes

Filters

Research Groups

Core Facilities

Start date

End date

Development of Cell-Permeable, Non-Helical Constrained Peptides to Target a Key Protein-Protein Interaction in Ovarian Cancer

The current consensus on the clinical management of intracranial ependymoma and its distinct molecular variants.

Master Regulators of Oncogenic KRAS Response in Pancreatic Cancer: An Integrative Network Biology Analysis.

Unravelling tumour heterogeneity using next-generation imaging: radiomics, radiogenomics, and habitat imaging.

Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial.

Deciphering the divergent roles of progestogens in breast cancer.

MRI measurements of reporter-mediated increases in transmembrane water exchange enable detection of a gene reporter.

Validation and Performance of a Standardized ctDNA NGS Assay across Two Laboratories